Drug intelligence / Profile preview

Altomoland

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Altomoland is a pharmaceutical drug whose main active ingredient is Reduced Glutathione (GSH). GSH is a tripeptide containing a sulfhydryl (SH) group, naturally synthesized in human cells. It plays a vital role in activating the redox system, activating SH enzymes, and facilitating detoxification processes within the body. Altomoland participates in the tricarboxylic acid cycle and sugar metabolism, contributing to energy production and acting as a coenzyme. It promotes the metabolism of carbohydrates, fats, and proteins by activating SH enzymes and regulates cell membrane metabolic processes. Furthermore, it binds to various exogenous and endogenous toxic substances, aiding in their detoxification and excretion. Altomoland is used for liver protection, mitigating drug toxicity (including from chemotherapy and antituberculosis drugs), preventing and treating radiation damage, combating free radicals as an antioxidant, and enhancing overall immunity.

Brand names
Altomoland
Other names
Reduced Glutathione TabletsReduced Glutathione for Injection阿拓莫兰还原型谷胱甘肽片注射用还原型谷胱甘肽Glutathione for Injection
02

Targets

IS (Indoxyl sulfate)

Beyond the preview

Go deeper on Altomoland.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Altomoland.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call